Synergy: A concept in search of a definition

Endocrinology

Volumn 154, Issue 11, 2013, Pages 3974-3977

  Berthoud, Hans Rudolf ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL;

APPETITE; BLOOD PRESSURE; BODY WEIGHT; ENDOCRINOLOGY; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; NOTE; PRIORITY JOURNAL;

ANIMALS; ENDOCRINE SYSTEM; ENERGY METABOLISM; HOMEOSTASIS; HORMONES; HUMANS; MODELS, BIOLOGICAL;

EID: 84886448649     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-1420     Document Type: Note

References (21)

1. Day JW, Ottaway N, Patterson JT, et al.Anew glucagon and GLP-1 co-agonist eliminates obesity in rodents. Nat Chem Biol. 2009;5: 749-757.
2. Greenway FL, Whitehouse MJ, Guttadauria M, et al. Rational design of a combination medication for the treatment of obesity. Obesity (Silver Spring). 2009;17: 30-39.
3. Rodgers RJ, TschöpMH,Wilding JP. Anti-obesity drugs: past, present and future. Dis Model Mech. 2012;5: 621-626.
4. Geary N. Understanding synergy. Am J Physiol Endocrinol Metab. 2013;304:E237-253.
5. Bliss CI. The toxicity of poisons applied jointly. Ann Appl Biol. 1939;26: 585-615.
6. Berenbaum MC. The expected effect of a combination of agents: the general solution. J Theor Biol. 1985;114: 413-431.
7. Chou TC. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev. 2006;58: 621-681.
8. Greco WR, Bravo G, Parsons JC. The search for synergy: a critical review from a response surface perspective. Pharmacol Rev. 1995; 47: 331-385.
9. Minto CF, Schnider TW, Short TG, Gregg KM, Gentilini A, Shafer SL. Response surface model for anesthetic drug interactions. Anesthesiology. 2000;92: 1603-1616.
10. Frye CA. Neurosteroids' effects and mechanisms for social, cognitive, emotional, and physical functions. Psychoneuroendocrinology. 2009;34(Suppl 1):S143-S161.
11. Luu-The V, Labrie F. The intracrine sex steroid biosynthesis pathways. Prog Brain Res. 2010;181: 177-192.
12. Micevych P, Sinchak K. The neurosteroid progesterone underlies estrogen positive feedback of the LH surge. Front Endocrinol (Lausanne). 2011;2:90.
13. Simpson ER, Misso M, Hewitt KN, et al. Estrogen-the good, the bad, and the unexpected. Endocr Rev. 2005;26: 322-330.
14. Heldring N, Pike A, Andersson S, et al. Estrogen receptors: how do they signal and what are their targets. Physiol Rev. 2007;87: 905-931.
15. Levin ER. Minireview: Extranuclear steroid receptors: roles in modulation of cell functions. Mol Endocrinol. 2011;25: 377-384.
16. Roepke TA, Ronnekleiv OK, Kelly MJ. Physiological consequences of membrane-initiated estrogen signaling in the brain. Front Biosci. 2011;16: 1560-1573.
17. Lieberman BA. The estrogen receptor activity cycle: dependence on multiple protein-protein interactions. Crit Rev Eukaryot Gene Expr. 1997;7(1-2): 43-59.
18. Kow LM, Pfaff DW. The membrane actions of estrogens can potentiate their lordosis behavior-facilitating genomic actions. Proc Natl Acad Sci USA. 2004;101: 12354-12357.
19. Loewe S. The problem of synergism and antagonism of combined drugs. Arzneimittelforschung. 1953;3: 285-290.
20. Shafer SL. All models are wrong. Anesthesiology. 2012;116: 240-241.
21. Greco WR, Faessel H, Levasseur L. The search for cytotoxic synergy between anticancer agents: a case of Dorothy and the ruby slippers? J Natl Cancer Inst. 1996;88: 699-700.